ICU Medical (ICUI) Stock Analysis & Winston Score

ICU Medical makes medical devices and supplies used in hospitals and clinics. Its main products include IV infusion systems, oncology drug delivery tools, and critical care equipment — things nurses and doctors use to safely give patients fluids and medications. The company serves hospitals, healthcare systems, and specialty clinics, and it is one of the larger dedicated infusion therapy companies in the United States. ICU Medical earns revenue by selling its devices and the disposable supplies that go with them, creating a recurring stream as hospitals reorder consumables regularly. The company operates primarily in the US but also sells internationally, and its 2022 acquisition of Smiths Medical significantly expanded its scale and product range. With a gross margin around 36% but a thin operating margin near 4%, the business is still working to absorb integration costs from that deal — improving profitability from that merger is the key near-term challenge and opportunity investors are watching.